| Stage: Seed |
 |
| Chairman: |
|
| CEO: |
Dr. Ben-Zion Rubinfeld |
| |
| |
 |
 |
|
| |
|
| |
|
| |
|
| |
|
|
 |
Mitam develops environmentally friendly, efficient, biological formulae and methods for tick/ parasitics control, based on entomopathogenic fungi. The biological agent is comprised of unique formulations containing live spores (conidia) of the fungi. The company’s products are designed for livestock and house pets by spraying and other existing methods, as well as a revolutionary application directly on their habitat. The potential of entomopathogenic fungi as tick control agents has been demonstrated in our laboratory and in field experiments with success.
The Need: The tick control market has great number of products and solutions, most of which are based on chemical formulations (like Amitraz). The main drawbacks of these products are: Ticks’ rapid mutations in response to the chemicals, and the harmful toxic effects on human beings, non-target animals, and the environment.
Market The ectoparasitic market has been one of the most dynamic sectors of the animal health market over the last few years, mainly due to new flea control products for pets. The market for veterinary antiparasitic treatments was transformed in the last two decades, first by the commercialization of endectocides and then by the phenomenal success of novel pet flea treatments. These new product groups have added substantially to the value of the market that is now estimated at close to US $3.5 billion, and that could be transformed again over the next 20 years by the development and application of both novel products and new parasite control strategies.
|